ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,006,000 | -9.6% | 57,726 | +0.0% | 0.00% | -20.0% |
| Q4 2020 | $4,433,000 | +34.7% | 57,700 | +31.1% | 0.01% | +25.0% |
| Q3 2020 | $3,291,000 | -12.9% | 44,000 | -26.7% | 0.00% | -20.0% |
| Q2 2020 | $3,777,000 | +49.9% | 60,000 | -0.0% | 0.01% | +25.0% |
| Q1 2020 | $2,520,000 | -7.6% | 60,006 | -0.0% | 0.00% | +33.3% |
| Q4 2019 | $2,726,000 | -0.7% | 60,007 | +0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,746,000 | -21.7% | 60,000 | +0.3% | 0.00% | -25.0% |
| Q2 2019 | $3,506,000 | +479.5% | 59,800 | +343.0% | 0.00% | +300.0% |
| Q1 2019 | $605,000 | -48.2% | 13,500 | -55.0% | 0.00% | -50.0% |
| Q4 2018 | $1,169,000 | +408.3% | 30,000 | +500.0% | 0.00% | – |
| Q3 2018 | $230,000 | -78.5% | 5,000 | -79.6% | 0.00% | -100.0% |
| Q2 2018 | $1,068,000 | -12.8% | 24,500 | -21.0% | 0.00% | 0.0% |
| Q1 2018 | $1,225,000 | – | 31,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |